(firstQuint)Safety and Tolerability of SOBI002 in Healthy Volunteers Following Single and Repeated Administration.

 This is a double-blind, placebo-controlled, randomized within dose cohort single and repeated dose study with sequential dose escalation.

 Eligible volunteers will be divided into dose cohorts and for each cohort, a new panel of 8 volunteers will be randomized to receive either SOBI002 (n=6) or placebo (n=2).

 SOBI002 will either be administered subcutaneously or intravenously.

.

 Safety and Tolerability of SOBI002 in Healthy Volunteers Following Single and Repeated Administration@highlight

The main purpose of this study is to assess the safety and tolerability of SOBI002 in healthy volunteers following single and repeated administration.

